AER Bills Likely To See Action In November Lame Duck Session
This article was originally published in The Tan Sheet
Executive Summary
Both the House and the Senate versions of the Adverse Event Reporting bill may be acted on in the week after November elections, according to the United Natural Products Alliance
You may also be interested in...
Democrats Expected To Put Supplement, Drug Regulation Under Microscope
Increased scrutiny of issues including the safety of dietary supplements and phenylephrine efficacy is likely as senior Democrats move into leadership roles on Congressional committees following the 2006 midterm elections
Democrats Expected To Put Supplement, Drug Regulation Under Microscope
Increased scrutiny of issues including the safety of dietary supplements and phenylephrine efficacy is likely as senior Democrats move into leadership roles on Congressional committees following the 2006 midterm elections
Democrats Expected To Put Supplement, Drug Regulation Under Microscope
Increased scrutiny of issues including the safety of dietary supplements and phenylephrine efficacy is likely as senior Democrats move into leadership roles on Congressional committees following the 2006 midterm elections